SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Biotechnology Cancer Cures
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Phil Cressman who wrote (92)8/15/1999 7:18:00 PM
From: chirodoc   of 226
 
BIOM is a stock that i follow quite closely.

i can't claim to be enough of a researcher to be certain that it will be a huge success. however, the PI and PII trials appear to be well tolerated and it does appear to improve longevity and quality of life.

if the PIII trials look as good as reports are touting, i can see them being able to get fast track. the fact that it is so non-toxic makes be think that it has a good shot relative to present cancer treatments that appear to have lots of untoward side effects.

also, since it helps the body mount a generalized immune response, i would surmise that it may help many types of cancers, thereby increasing the odds of a blockbuster.

there is a lot of good discussion on yahoo board but you have to overcome a few regular, nasty short sellers.

curtis
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News